Clinical Trials Browser

Phase 2 × Breast Neoplasms × bicalutamide × Clear all

NCT03650894 2025-03-10

Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

Phase 2 Active not recruiting

Breast Neoplasms

NCT02299999 2025-01-15

SAFIR02_Breast

Phase 2 Active not recruiting

Breast Neoplasms

NCT00468715 2022-08-03

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

28 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02697032 2019-11-27

FDHT PET and Bicalutamide in Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT02348281 2018-01-23

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Phase 2 Terminated

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT02910050 2017-12-22

BETTER

Phase 2 Unknown

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02353988 2015-02-03

Arbre

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis